Matches in Wikidata for { <http://www.wikidata.org/entity/Q80726137> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- Q80726137 description "artículu científicu espublizáu n'agostu de 2007" @default.
- Q80726137 description "scientific article published on 01 August 2007" @default.
- Q80726137 description "wetenschappelijk artikel" @default.
- Q80726137 description "наукова стаття, опублікована в серпні 2007" @default.
- Q80726137 name "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 name "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 type Item @default.
- Q80726137 label "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 label "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 prefLabel "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 prefLabel "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 P1433 Q80726137-5BC7E699-5B8F-4079-AFD7-B85496A1690C @default.
- Q80726137 P1476 Q80726137-96EB6C0F-D6F1-495A-BE37-15482929D986 @default.
- Q80726137 P2093 Q80726137-05D37312-5FB2-4531-9784-3FA25FDCE151 @default.
- Q80726137 P2093 Q80726137-46E02307-7BD1-492D-967F-2972D78899CF @default.
- Q80726137 P2093 Q80726137-50A097D1-67A5-44AB-AE74-3A0D8E56FA9B @default.
- Q80726137 P2093 Q80726137-577F07B1-9F37-43C7-B5B3-8AF849592A17 @default.
- Q80726137 P2093 Q80726137-5C1F01B8-16AF-4340-9BA4-C1777DC800FC @default.
- Q80726137 P2093 Q80726137-6B693C3B-20D9-4CC7-BCA1-32778E8F9432 @default.
- Q80726137 P2093 Q80726137-AB77A855-64F6-41F9-84BF-1F2E9D923464 @default.
- Q80726137 P2093 Q80726137-B63A6390-B42D-4157-B86C-21042A30A9D5 @default.
- Q80726137 P2093 Q80726137-EC904A47-EC57-4DAE-B661-58631CD510CD @default.
- Q80726137 P304 Q80726137-39B7249C-BC31-4409-9061-F69483614045 @default.
- Q80726137 P31 Q80726137-8F65F40A-1A6B-4F6B-9CBA-060C83D1E1D5 @default.
- Q80726137 P356 Q80726137-CBFDE31F-86F4-4047-93D0-F258B67E8759 @default.
- Q80726137 P433 Q80726137-AAD2A3A9-D3CE-45E7-8D6D-5ADEC72F768E @default.
- Q80726137 P478 Q80726137-22D3C7CE-4609-4B6E-A522-86822EEE12E3 @default.
- Q80726137 P50 Q80726137-55D12B73-5221-434A-B16C-6BAE2A0519AE @default.
- Q80726137 P50 Q80726137-8279A358-C965-4011-AA92-2A94B99BC4AE @default.
- Q80726137 P577 Q80726137-DB850C56-5570-4956-94DD-CE005314D08F @default.
- Q80726137 P698 Q80726137-FB89A8FE-BB62-4995-BBA1-FAF971F0C67A @default.
- Q80726137 P921 Q80726137-4709BA0D-874F-41B9-93D5-B4D45334E6B4 @default.
- Q80726137 P921 Q80726137-6380A378-37D4-4C42-AFC4-E39A817E7BDF @default.
- Q80726137 P356 1078-0432.CCR-07-0004 @default.
- Q80726137 P698 17671135 @default.
- Q80726137 P1433 Q332253 @default.
- Q80726137 P1476 "Phase I pharmacokinetic study of the safety and tolerability of lapatinib (GW572016) in combination with oxaliplatin/fluorouracil/leucovorin (FOLFOX4) in patients with solid tumors" @default.
- Q80726137 P2093 "Deborah A Smith" @default.
- Q80726137 P2093 "Dirk J Richel" @default.
- Q80726137 P2093 "Henk Boot" @default.
- Q80726137 P2093 "Kevin M Koch" @default.
- Q80726137 P2093 "Lini Pandite" @default.
- Q80726137 P2093 "Marianne Keessen" @default.
- Q80726137 P2093 "Melissa Versola" @default.
- Q80726137 P2093 "Walter L Vervenne" @default.
- Q80726137 P2093 "Wandena S Siegel-Lakhai" @default.
- Q80726137 P304 "4495-4502" @default.
- Q80726137 P31 Q13442814 @default.
- Q80726137 P356 "10.1158/1078-0432.CCR-07-0004" @default.
- Q80726137 P433 "15 Pt 1" @default.
- Q80726137 P478 "13" @default.
- Q80726137 P50 Q23771643 @default.
- Q80726137 P50 Q89824209 @default.
- Q80726137 P577 "2007-08-01T00:00:00Z" @default.
- Q80726137 P698 "17671135" @default.
- Q80726137 P921 Q323936 @default.
- Q80726137 P921 Q422327 @default.